- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on HER2 Positive Advanced Gastric Cancer in Denmark
Total 90 results
-
Dorte NielsenTerminated
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastItaly, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
-
Aalborg University HospitalRecruitingCancer | Gastric Cancer | Gastro Esophageal Junctional CancerDenmark
-
Vejle HospitalBispebjerg Hospital; Danish Cancer SocietyCompleted
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
Bispebjerg HospitalDanish Cancer Society; The Novo Nordic Foundation; Lundbeck Foundation; Sygekassernes... and other collaboratorsCompleted
-
Odense University HospitalCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Liver CancerDenmark
-
Odense University HospitalCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Liver Cancer | Lymph NodesDenmark
-
REHPA, The Danish Knowledge Centre for Rehabilitation...University of Southern DenmarkCompleted
-
Odense University HospitalAarhus University Hospital; University of Copenhagen; Aalborg University HospitalRecruitingHER2-positive Breast Cancer | CardiotoxicityDenmark
-
Seagen Inc.RecruitingHER2-positive Breast CancerUnited States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer; HER2-positive; MetastaticUnited States, Belgium, Canada, Denmark, Italy, Spain, Hungary, Taiwan, Turkey, France, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, United Kingdom, China, South Africa, Israel, Russian Federation, Argentina, ... and more
-
Per PfeifferCompletedFirst-line Treatment for Patients With Non-resectable Gastric Cancer or Cancer of the Esophagus orDenmark
-
Seagen Inc.CompletedHER2 Positive Breast CancerUnited States, Spain, Belgium, Germany, Israel, France, United Kingdom, Austria, Denmark, Italy, Australia, Canada, Czechia, Portugal, Switzerland
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
Novartis PharmaceuticalsCompletedALK-positive Advanced TumorsItaly, Spain, Denmark, United States
-
University of CopenhagenCompletedGastric Cancer | Esophageal CancerDenmark
-
Signe HarderCompleted
-
Rigshospitalet, DenmarkRecruitingGastric Cancer | Esophageal CancerDenmark
-
Michael Bau MortensenCompletedGastric Cancer | Gastric AdenocarcinomaSweden, Denmark
-
AstraZenecaCompletedHepatic Impairment | Advanced CancerNetherlands, Denmark
-
Aarhus University HospitalOdense University Hospital; Rigshospitalet, Denmark; University of Copenhagen; Herning... and other collaboratorsRecruitingBreast Cancer Female | Estrogen Receptor Positive TumorDenmark
-
University of CopenhagenCompletedGastric Cancer | Esophageal Cancer | Uterine CancerDenmark
-
Zealand University HospitalOdense University HospitalUnknown
-
Jesper Frank Christensen, PhDCompletedGastro-esophageal CancerDenmark
-
Rigshospitalet, DenmarkTerminatedGastric CancerDenmark
-
Aarhus University HospitalDanish Cancer SocietyRecruitingMetastatic Breast Cancer | Adiposity | Estrogen-receptor-positive Breast CancerDenmark
-
Danish Head and Neck Cancer GroupUnknownRadiotherapy | Locally Advanced Head and Neck Cancer | Hypoxic RadioresistanceDenmark
-
Vejle HospitalAarhus University HospitalTerminated
-
Per PfeifferCompletedLocally Advanced Pancreatic CancerDenmark
-
Vrije Universiteit BrusselKing's College London; University of Copenhagen; Erasmus Medical Center; University... and other collaboratorsCompletedAdvanced CancerBelgium, Netherlands, Denmark, Ireland, United Kingdom, Italy
-
Rigshospitalet, DenmarkRecruitingGastro-esophageal CancerDenmark
-
Herlev HospitalActive, not recruitingBorderline Resectable, Locally Advanced or Metastatic Pancreatic CancerDenmark
-
Herlev and Gentofte HospitalRigshospitalet, Denmark; University of CopenhagenCompletedNon Small Cell Lung Cancer | Advanced Cancer | Pancreas Cancer | Biliary Tract CancerDenmark
-
Allarity TherapeuticsCompletedPhase 1: Advanced or Refractory Solid Tumours | Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin CancerDenmark
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors, Excluding Breast CancerNetherlands, Switzerland, Denmark, United States
-
BayerNot yet recruitingAdvanced Non-small Cell Lung Cancer | HER2 MutationUnited States, Korea, Republic of, Belgium, China, Japan, Taiwan, Denmark, Germany, Israel, Italy, United Kingdom, Bulgaria, Portugal, Switzerland, Greece, Turkey, Sweden, France, Singapore, Mexico, Spain, Netherlands, Poland, Brazil, A... and more
-
Aalborg University HospitalActive, not recruitingRectal Cancer | Rectal Adenocarcinoma | Locally Advanced Malignant NeoplasmDenmark
-
Claus Lindbjerg AndersenUniversity of AarhusRecruitingGastrointestinal Neoplasms | Colonic Diseases | Colorectal Neoplasms | Rectal Diseases | Colorectal Cancer | Rectal Cancer | Rectal Neoplasms | Colonic Neoplasms | Gastrointestinal Cancer | Colo-rectal Cancer | Colonic Cancer | Digestive System Neoplasm | Digestive System Disease | Gastro-Intestinal Disorder | ctDNADenmark
-
Vejle HospitalRecruiting
-
Zealand University HospitalRigshospitalet, Denmark; Herlev HospitalUnknownNeoadjuvant Therapy | Locally Advanced Rectal Cancer | Electrochemotherapy | Down StagingDenmark
-
University of Southern DenmarkOdense University HospitalCompletedBreast Cancer | Gastric Cancer | Rectal Cancer | Bile Duct Cancer | Colon Cancer | Pancreas Cancer | Oesophageal Cancer | Adverse Drug EventDenmark
-
MacroGenicsCompletedHER-2 Positive Breast Cancer | Metastatic NeoplasmUnited States, Spain, Italy, Canada, Israel, Belgium, Germany, Czechia, Austria, Korea, Republic of, Denmark, United Kingdom, Portugal, France, Poland, Netherlands, Finland, Puerto Rico
-
Rigshospitalet, DenmarkNot yet recruitingGastro-Esophageal CancerDenmark
-
Acacia Pharma LtdCompletedXerostomia in Advanced Cancer PatientsUnited Kingdom, Denmark
-
Herlev and Gentofte HospitalNot yet recruitingKidney Cancer | Urologic Neoplasms | Metastatic Renal Cell Carcinoma | Urologic Cancer | Advanced Renal Cell Carcinoma | Kidney NeoplasmDenmark
-
Michael Bau MortensenOdense University HospitalUnknownEsophageal Cancer | Gastro-esophageal Junction CancerDenmark
-
Orion Corporation, Orion PharmaCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticFinland, France, Denmark
-
University of AarhusCompletedThrombosis | Gastric Cancer | Venous Thromboembolism | Pancreas Cancer | Pulmonary Embolism | Deep Venous Thrombosis | Esophagus CancerDenmark